Evolent Health (NYSE:EVH) Price Target Lowered to $33.00 at Citigroup
MarketBeatCitigroup decreased their target price on Evolent Health from $35.00 to $33.00 and set a “buy” rating on the stock in a research note on Tuesday.
Citigroup decreased their target price on Evolent Health from $35.00 to $33.00 and set a “buy” rating on the stock in a research note on Tuesday.